This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovations of Robert Anderson Noe
Introduction
Robert Anderson Noe is an accomplished inventor based in Hurdle Mills, North Carolina. He has made significant contributions to the field of medical treatments, particularly in relation to diabetes. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Robert Anderson Noe holds a patent for Kv2.1 antagonists. This invention relates to methods of treating non-insulin dependent diabetes mellitus. It includes antagonists of the delayed rectifier potassium channel Kv2.1, methods for using and preparing these antagonists, and assays for identifying such antagonists. This patent represents a significant advancement in diabetes treatment options.
Career Highlights
Noe is associated with SmithKline Beecham Corporation, where he has contributed to various research initiatives. His work has focused on developing innovative solutions to complex medical problems. His dedication to research and development has positioned him as a notable figure in his field.
Collaborations
Throughout his career, Robert Anderson Noe has collaborated with esteemed colleagues such as Jerzy Ryszard Szewczyk and Stephen Andrew Thomson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Robert Anderson Noe's contributions to the field of diabetes treatment through his patent for Kv2.1 antagonists highlight his innovative spirit and commitment to improving health outcomes. His work continues to inspire advancements in medical research and treatment methodologies.